Valerian officinalis l. root extract: no evidence for clinically relevant interactions
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: NIEBER, Karen (University of Leipzig, Institute of Pharmacy, Leipzig, Germany)
- Co-author(s): Hoser, Stefanie (University of Leipzig, Leipzig, Germany)
Michael, Sebastian (L, Waldheim, Germany)
Background: In recent popular publications directed to cancer patients as well as in widely-used patient information websites (e. g. www.cancer.org or www.mskcc.org) valerian is claimed to have a potential of adverse interactions with anti-cancer drugs, thereby questioning its use (1) as a safe replacement for benzodiazepines. Aim: Therefore a.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.